Rosoxacin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MB01

CAS registry number (Chemical Abstracts Service)

0040034-42-2

Chemical Formula

C17-H14-N2-O3

Molecular Weight

294

Therapeutic Category

Antiinfective, quinolin-derivative

Chemical Name

3-Quinolinecarboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-

Foreign Names

• Rosoxacinum (Latin)
• Rosoxacin (German)
• Rosoxacine (French)
• Rosoxacino (Spanish)

Generic Names

• Acrosoxacin (OS: BAN)
• Rosoxacin (OS: USAN, BAN)
• Rosoxacine (OS: DCF)
• TO 133 (IS)
• Win 35213 (IS)

Brand Names

• Eradacil
  Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Jordan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.